May 25, 2021
BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports
Pompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a…
Pharmaceuticals, Biotechnology and Life Sciences
Pompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a…
Botond Roska, Director at the Institute of Molecular and Clinical Ophthalmology Basel. At the IOB we are working on the…
CpG-STAT3siRNA is a Distinctive RNA Therapy and Immunotherapy Developed at City of Hope A Phase 1 Clinical Trial Will be…
BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company…
LA JOLLA, Calif, May 24, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company…
Qelbree™ has proven efficacy in ADHD, with improvement in symptoms as early as the first weekROCKVILLE, Md., May 24, 2021…
– Virtual Panel to be Held on Wednesday, May 26th, 11:00am Eastern Time – – Discussion to be Moderated by…
FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel…
SOUTH SAN FRANCISCO, Calif., May 23, 2021 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) will host a conference call…
HAV performance in the clinical setting as an arteriovenous reconstruction underscores the potential for use as vascular access conduits for…